Data / Form D filings / Cyclerion Therapeutics, Inc.
Cyclerion Therapeutics, Inc.: Form D filings
Cyclerion Therapeutics, Inc., a pharmaceuticals company in Cambridge, MA, filed 4 Form D notices with the SEC between 2019 and 2023. The latest, on May 25, 2023, reports $5 million sold of a $5 million offering to 1 investor.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 245 First Street, 18th Floor, Cambridge, MA, 02142
- Phone
- (857) 327-8778
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Massachusetts
- Year incorporated
- 2018
- Revenue range
- $1,000,001 - $5,000,000
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1755237
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| May 25, 2023 | New notice | $5,000,000 | $5,000,000 | 1 | May 19, 2023 | sec.gov | |
| Jun 17, 2021 | New notice | $18,028,000 | $18,028,000 | 7 | Jun 7, 2021 | sec.gov | |
| Aug 11, 2020 | New notice | $24,250,000 | $24,250,000 | 2 | Jul 29, 2020 | sec.gov | |
| Apr 17, 2019 | New notice | $175,000,000 | $175,000,000 | 49 | Apr 2, 2019 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Errol M. De Souza | Director | |
| Steven M. Hyman | Director | |
| Terrance M. McGuire | Director | |
| Peter M. Hecht | Director, Executive Officer | |
| Anjeza M. Gjino | Executive Officer | |
| Cheryl M. Gault | Executive Officer | |
| Ole M. Isacson | Director |
Other pharmaceuticals companies in Massachusetts that filed recently
- Land Therapeutics Inc. $17.5 million · Oct 21, 2026
- Crosslink Therapeutics Inc. $5.5 million · Oct 20, 2026
- Sentonix, Inc. $12.7 million · Aug 20, 2026
Every Form D from the week of May 22, 2023 · All recent filings in Massachusetts · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Cyclerion Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.